相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Pharmacokinetics of Tenofovir following Intravaginal and Intrarectal Administration of Tenofovir Gel to Rhesus Macaques
Jeremy Nuttall et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
Innate Immune Activation Enhances HIV Acquisition in Women, Diminishing the Effectiveness of Tenofovir Microbicide Gel
Vivek Naranbhai et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
Evaluation of the Mean Corpuscular Volume of Peripheral Blood Mononuclear Cells of HIV Patients by a Coulter Counter To Determine Intracellular Drug Concentrations
Marco Simiele et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Structure and Function of Intercellular Junctions in Human Cervical and Vaginal Mucosal Epithelia
Caitlin D. Blaskewicz et al.
BIOLOGY OF REPRODUCTION (2011)
Pharmacological considerations for tenofovir and emtricitabine to prevent HIV infection
Peter L. Anderson et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Estimating Volume of Cervicovaginal Secretions in Cervicovaginal Lavage Fluid Collected for Measurement of Genital HIV-1 RNA Levels in Women
Caroline Mitchell et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women
Salim S. Abdool Karim et al.
LANCET (2011)
A Randomized Trial to Assess Anti-HIV Activity in Female Genital Tract Secretions and Soluble Mucosal Immunity Following Application of 1% Tenofovir Gel
Marla J. Keller et al.
PLOS ONE (2011)
A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel
Jill L. Schwartz et al.
PLOS ONE (2011)
Penetration of Tenofovir and Emtricitabine in Mucosal Tissues: Implications for Prevention of HIV-1 Transmission
Kristine B. Patterson et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men.
Robert M. Grant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Effectiveness and Safety of Tenofovir Gel, an Antiretroviral Microbicide, for the Prevention of HIV Infection in Women
Quarraisha Abdool Karim et al.
SCIENCE (2010)
Pilot Pharmacokinetic Study of Human Immunodeficiency Virus-Infected Patients Receiving Tenofovir Disoproxil Fumarate (TDF): Investigation of Systemic and Intracellular Interactions between TDF and Abacavir, Lamivudine, or Lopinavir-Ritonavir
Alain Pruvost et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis
Julie B. Dumond et al.
AIDS (2007)
Liquid chromatography-tandem mass spectrometric determination of tenofovir-diphosphate in human peripheral blood mononuclear cells
Tracy King et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2006)
Intracellular pharmacokinetics of tenofovir diphosphate, carbovir triphosphate, and lamivudine triphosphate in patients receiving triple-nucleoside regimens
T Hawkins et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2005)
Tenofovir disoproxil fumarate - Clinical pharmacology and pharmacokinetics
BP Kearney et al.
CLINICAL PHARMACOKINETICS (2004)
Metabolism of tenofovir and didanosine in quiescent or stimulated human peripheral blood mononuclear cells
BL Robbins et al.
PHARMACOTHERAPY (2003)
Metabolic activation of nucleoside and nucleotide reverse transcriptase inhibitors in dendritic and Langerhans cells
J Balzarini et al.
AIDS (2002)
Phase I/II trial of the pharmacokinetics, safety, and antiretroviral activity of tenofovir disoproxil fumarate in human immunodeficiency virus-infected adults
P Barditch-Crovo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
分享论文
